Mar 4, 2026

Unlocking the Potential of Radioligand Therapy for Targeted Cancer Therapy

Topics of discussion: Demystifying targeted radiopharmaceutical innovation; Building AdvanCell: advancing next-generation radioligand therapies; From RayzeBio to Bristol Myers Squibb: scaling a radiopharma start-up; What does it take to translate radioligand science into approved medicines?; Entrepreneurship, strategy and leadership in precision oncology